Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/9/2026 | $50.00 | Overweight | Analyst |
| 6/9/2026 | $48.00 | Market Outperform | CJS Securities |
| 3/31/2026 | $30.00 | Neutral → Buy | UBS |
| 1/12/2026 | $31.00 | Buy → Neutral | UBS |
| 3/26/2025 | $14.00 | Neutral → Buy | UBS |
| 10/11/2023 | $7.00 → $4.25 | Buy → Neutral | UBS |
| 6/9/2022 | $14.00 | Overweight | Morgan Stanley |
| 4/14/2022 | $15.00 | Buy | UBS |
4 - Perimeter Solutions, Inc. (0001880319) (Issuer)
4 - Perimeter Solutions, SA (0001880319) (Issuer)
4/A - Perimeter Solutions, Inc. (0001880319) (Issuer)
4 - Perimeter Solutions, Inc. (0001880319) (Issuer)
4 - Perimeter Solutions, Inc. (0001880319) (Issuer)
Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature
Medical Manufacturing Technologies (MMT), a Perimeter Solutions company and a leading provider of precision manufacturing technologies for the medical device and advanced industrial markets, today announced the appointment of Grant Bowman as President. Bowman will guide the company's next phase of growth while continuing MMT's customer-first approach and long-standing tradition of solving complex manufacturing challenges. As MMT enters this new phase of leadership, customers can expect the same experienced teams and responsive support across the company's Catheter, Guidewire, Abrasive, and Automation Technologies, and the company’s broader portfolio of solutions. This press release feature
First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06 Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026 CLAYTON, Mo., May 06, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missio
144 - Perimeter Solutions, Inc. (0001880319) (Subject)
144 - Perimeter Solutions, Inc. (0001880319) (Subject)
8-K - Perimeter Solutions, Inc. (0001880319) (Filer)
Analyst initiated coverage of Perimeter Solutions with a rating of Overweight and set a new price target of $50.00
CJS Securities initiated coverage of Perimeter Solutions with a rating of Market Outperform and set a new price target of $48.00
UBS upgraded Perimeter Solutions from Neutral to Buy and set a new price target of $30.00
First quarter Net Income of $72.9M and Adjusted Net Income of $9.0M Continued value driver execution and recent acquisitions drove first quarter Adjusted EBITDA of $41.2M First quarter Earnings Per Diluted Share of $0.44 and Adjusted Earnings Per Diluted Share of $0.06 Entered into key five-year contracts with the United States Defense Logistics Agency for suppressants and with California Department of Forestry for retardants in April 2026 CLAYTON, Mo., May 06, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missio
CLAYTON, Mo., April 21, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions (NYSE: PRM) ("Perimeter" or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, announced today it will release its financial results for the first quarter 2026 on Wednesday, May 6, 2026, before the market opens. The Company will host a conference call to discuss these results at 8:30 a.m. ET on the same day. The presentation will be led by CEO Haitham Khouri, CFO Kyle Sable, and Head of Investor Relations Seth Barker. The live webcast of the call can be accessed through Perimeter's investor relations website at
Full year Net Loss of $206.4M and Adjusted Net Income of $206.7M Continued value driver execution drove full year Adjusted EBITDA of $331.7M Full year Loss Per Diluted Share of $1.37 and Adjusted Earnings Per Diluted Share of $1.34 Specialty Products Segment acquired add-on product lines in Q4 2025, and MMT in Q1 2026 CLAYTON, Mo., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Perimeter Solutions, Inc. (NYSE:PRM) ("Perimeter," "Perimeter Solutions," or the "Company"), a leading provider of industrial products and services that support critical and complex customer missions across a range of niche applications, today reported financial results for its fourth quarter, and full year, ended December 3
Robbie Atkinson appointed as CEO and Brian Highley appointed as Chairman KKR today announced the launch of Allyntra ("Allyntra" or the "Company"), a newly formed precision-engineered solutions platform serving medical technology and other precision end markets. Allyntra builds on KKR’s existing investment in Precipart through its Health Care Strategic Growth Fund II, with Precipart serving as one of the foundational businesses within the platform. KKR is committing meaningful additional capital to support Allyntra’s growth by acquiring and integrating complementary best-in-class businesses and through continued investment in innovation and commercial expansion. This press release feature
Medical Manufacturing Technologies (MMT), a Perimeter Solutions company and a leading provider of precision manufacturing technologies for the medical device and advanced industrial markets, today announced the appointment of Grant Bowman as President. Bowman will guide the company's next phase of growth while continuing MMT's customer-first approach and long-standing tradition of solving complex manufacturing challenges. As MMT enters this new phase of leadership, customers can expect the same experienced teams and responsive support across the company's Catheter, Guidewire, Abrasive, and Automation Technologies, and the company’s broader portfolio of solutions. This press release feature
SC 13G/A - Perimeter Solutions, Inc. (0001880319) (Subject)
SC 13G/A - Perimeter Solutions, SA (0001880319) (Subject)
SC 13G/A - Perimeter Solutions, SA (0001880319) (Subject)